• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用B族链球菌III型多糖-β C蛋白共轭物对小鼠进行母体免疫可引发针对多种血清型的保护性抗体。

Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes.

作者信息

Madoff L C, Paoletti L C, Tai J Y, Kasper D L

机构信息

Channing Laboratory, Brigham and Women's Hospital, Boston, Massachusetts 02115.

出版信息

J Clin Invest. 1994 Jul;94(1):286-92. doi: 10.1172/JCI117319.

DOI:10.1172/JCI117319
PMID:7518832
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC296308/
Abstract

Group B streptococcal infection is a major cause of neonatal mortality. Antibody to the capsular polysaccharide protects against invasive neonatal disease, but immunization with capsular polysaccharides fails to elicit protective antibody in many recipients. Conjugation of the polysaccharide to tetanus toxoid has been shown to increase immune response to the polysaccharide. In animal models, C proteins of group B streptococci are also protective determinants. We examined the ability of the beta C protein to serve in the dual role of carrier for the polysaccharide and protective immunogen. Type III polysaccharide was covalently coupled to beta C protein by reductive amination. Immunization of rabbits with the polysaccharide-protein conjugate elicited high titers of antibody to both components, and the serum induced opsonophagocytic killing of type III, Ia/C, and Ib/C strains of group B streptococci. Female mice were immunized with the conjugate vaccine and then bred; 93% of neonatal pups born to these dams vaccinated with conjugate survived type III group B streptococcal challenge and 76% survived type Ia/C challenge, compared with 3% and 8% survival, respectively, in controls (P < 0.001). The beta C protein acted as an effective carrier for the type III polysaccharide while simultaneously induced protective immunity against beta C protein--containing strains of group B streptococci.

摘要

B族链球菌感染是新生儿死亡的主要原因。针对荚膜多糖的抗体可预防新生儿侵袭性疾病,但用荚膜多糖进行免疫接种在许多受种者中未能引发保护性抗体。已证明将多糖与破伤风类毒素结合可增强对多糖的免疫反应。在动物模型中,B族链球菌的C蛋白也是保护性决定因素。我们研究了β-C蛋白作为多糖载体和保护性免疫原的双重作用的能力。III型多糖通过还原胺化与β-C蛋白共价偶联。用多糖-蛋白偶联物免疫兔子可引发针对两种成分的高滴度抗体,并且血清可诱导对B族链球菌III型、Ia/C型和Ib/C型菌株的调理吞噬杀伤作用。用偶联疫苗免疫雌性小鼠,然后进行繁殖;这些接种偶联疫苗的母鼠所生的新生幼崽中,93%在受到III型B族链球菌攻击后存活,76%在受到Ia/C型攻击后存活,而对照组的存活率分别为3%和8%(P<0.001)。β-C蛋白作为III型多糖的有效载体,同时诱导针对含β-C蛋白的B族链球菌菌株的保护性免疫。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03a7/296308/1d807b6e39a3/jcinvest00019-0307-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03a7/296308/1d807b6e39a3/jcinvest00019-0307-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03a7/296308/1d807b6e39a3/jcinvest00019-0307-a.jpg

相似文献

1
Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes.用B族链球菌III型多糖-β C蛋白共轭物对小鼠进行母体免疫可引发针对多种血清型的保护性抗体。
J Clin Invest. 1994 Jul;94(1):286-92. doi: 10.1172/JCI117319.
2
Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine.通过用四价B族链球菌多糖-破伤风类毒素结合疫苗进行母体免疫,对新生小鼠进行多种B族链球菌(GBS)血清型感染的保护。
Infect Immun. 1994 Aug;62(8):3236-43. doi: 10.1128/iai.62.8.3236-3243.1994.
3
Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines.αC蛋白作为III型荚膜多糖的载体以及B族链球菌疫苗中的保护性蛋白。
Infect Immun. 1999 May;67(5):2491-6. doi: 10.1128/IAI.67.5.2491-2496.1999.
4
Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.一种抗B族链球菌III型多糖-蛋白结合疫苗在动物体内的免疫原性。
J Clin Invest. 1990 Nov;86(5):1428-33. doi: 10.1172/JCI114858.
5
Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.V 型 B 族链球菌多糖-破伤风类毒素结合疫苗在动物体内的免疫原性和保护活性
J Infect Dis. 1995 Apr;171(4):879-84. doi: 10.1093/infdis/171.4.879.
6
Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine.I a型多糖-破伤风类毒素结合疫苗对I a型和I b型B族链球菌保护性抗体的刺激作用。
Infect Immun. 1993 Nov;61(11):4760-6. doi: 10.1128/iai.61.11.4760-4766.1993.
7
An oligosaccharide-tetanus toxoid conjugate vaccine against type III group B Streptococcus.一种针对B族链球菌III型的寡糖-破伤风类毒素结合疫苗。
J Biol Chem. 1990 Oct 25;265(30):18278-83.
8
Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.对III型B族链球菌多糖-破伤风类毒素结合疫苗的免疫反应。
J Clin Invest. 1996 Nov 15;98(10):2308-14. doi: 10.1172/JCI119042.
9
Functional activity of antibodies to the group B polysaccharide of group B streptococci elicited by a polysaccharide-protein conjugate vaccine.由多糖-蛋白结合疫苗引发的针对B族链球菌B族多糖的抗体的功能活性。
Infect Immun. 1994 May;62(5):1593-9. doi: 10.1128/iai.62.5.1593-1599.1994.
10
Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus.用B族链球菌多糖疫苗对孕妇进行免疫接种。
N Engl J Med. 1988 Nov 3;319(18):1180-5. doi: 10.1056/NEJM198811033191802.

引用本文的文献

1
Using Surface Immunogenic Protein as a Carrier Protein to Elicit Protective Antibody to Multiple Serotypes for Candidate Group B Streptococcal Glycan Conjugate Vaccines.使用表面免疫原性蛋白作为载体蛋白,针对B族链球菌聚糖结合疫苗候选物引发针对多种血清型的保护性抗体。
Vaccines (Basel). 2024 May 24;12(6):573. doi: 10.3390/vaccines12060573.
2
Vaccines for Perinatal and Congenital Infections-How Close Are We?围产期和先天性感染疫苗——我们距离成功还有多远?
Front Pediatr. 2020 Dec 15;8:569. doi: 10.3389/fped.2020.00569. eCollection 2020.
3
The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultations.

本文引用的文献

1
A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults.基于人群的非妊娠成人B族链球菌侵袭性疾病评估。
N Engl J Med. 1993 Jun 24;328(25):1807-11. doi: 10.1056/NEJM199306243282503.
2
Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections.蛋白质核糖:一种新型B族链球菌细胞表面蛋白,可提供保护性免疫,且大多数引起侵袭性感染的菌株都可表达该蛋白。
J Exp Med. 1993 Jun 1;177(6):1593-603. doi: 10.1084/jem.177.6.1593.
3
Antibody profiles to the group B streptococcal beta antigen in maternal and infant paired sera.
免疫保护相关因素在 B 型链球菌疫苗获得许可、政策决策和用于母亲免疫接种的路径中的作用:来自世界卫生组织磋商的考虑。
Vaccine. 2019 May 27;37(24):3190-3198. doi: 10.1016/j.vaccine.2019.04.039. Epub 2019 Apr 25.
4
Non-Pilus, Cell Wall-Anchored Proteins: Involvement in Colonization and Pathogenesis and Potential as Vaccine Candidates.非菌毛、细胞壁锚定蛋白:在定植和发病机制中的作用及作为疫苗候选物的潜力。
Front Immunol. 2018 Apr 5;9:602. doi: 10.3389/fimmu.2018.00602. eCollection 2018.
5
Association between antibodies against group B Streptococcus surface proteins and recto-vaginal colonisation during pregnancy.抗 B 群链球菌表面蛋白抗体与孕期直肠-阴道定植的相关性。
Sci Rep. 2017 Nov 28;7(1):16454. doi: 10.1038/s41598-017-16757-9.
6
Group B vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries.B组疫苗研发:现状与未来考量,重点关注低收入和中等收入国家的前景
F1000Res. 2016 Sep 22;5:2355. doi: 10.12688/f1000research.9363.1. eCollection 2016.
7
Maternal vaccination: moving the science forward.孕产妇疫苗接种:推动科学进步。
Hum Reprod Update. 2015 Jan-Feb;21(1):119-35. doi: 10.1093/humupd/dmu041. Epub 2014 Jul 11.
8
Fine specificity and cross-reactions of monoclonal antibodies to group B streptococcal capsular polysaccharide type III.针对 B 族链球菌荚膜多糖 III 型的单克隆抗体的精细特异性和交叉反应性。
Vaccine. 2012 Jul 6;30(32):4849-58. doi: 10.1016/j.vaccine.2012.05.006. Epub 2012 May 23.
9
Streptococcus adherence and colonization.链球菌的黏附和定植。
Microbiol Mol Biol Rev. 2009 Sep;73(3):407-50, Table of Contents. doi: 10.1128/MMBR.00014-09.
10
Recombinant group B Streptococcus alpha-like protein 3 is an effective immunogen and carrier protein.重组B族链球菌α样蛋白3是一种有效的免疫原和载体蛋白。
Clin Vaccine Immunol. 2008 Jul;15(7):1035-41. doi: 10.1128/CVI.00030-08. Epub 2008 May 7.
母婴配对血清中抗B族链球菌β抗原的抗体谱。
APMIS. 1993 Jan;101(1):41-9. doi: 10.1111/j.1699-0463.1993.tb00079.x.
4
Responses of children to booster immunization with their primary conjugate Haemophilus influenzae type B vaccine or with polyribosylribitol phosphate conjugated with diphtheria toxoid.儿童对其主要的B型流感嗜血杆菌结合疫苗或与白喉类毒素结合的聚核糖核糖醇磷酸进行加强免疫的反应。
J Pediatr. 1993 Mar;122(3):410-3. doi: 10.1016/s0022-3476(05)83428-6.
5
Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine.I a型多糖-破伤风类毒素结合疫苗对I a型和I b型B族链球菌保护性抗体的刺激作用。
Infect Immun. 1993 Nov;61(11):4760-6. doi: 10.1128/iai.61.11.4760-4766.1993.
6
Non-epitope-specific suppression of the antibody response to Haemophilus influenzae type b conjugate vaccines by preimmunization with vaccine components.通过用疫苗成分进行预免疫对b型流感嗜血杆菌结合疫苗抗体反应进行非表位特异性抑制。
Infect Immun. 1993 Feb;61(2):432-8. doi: 10.1128/iai.61.2.432-438.1993.
7
Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates.A、B和C群脑膜炎球菌多糖-破伤风类毒素结合物的免疫化学
J Immunol. 1981 Sep;127(3):1011-8.
8
A surface receptor specific for human IgA on group B streptococci possessing the Ibc protein antigen.具有Ibc蛋白抗原的B族链球菌上的一种对人IgA特异的表面受体。
J Exp Med. 1984 Nov 1;160(5):1467-75. doi: 10.1084/jem.160.5.1467.
9
Correlation between low levels of maternal IgG antibodies to R protein and neonatal septicemia with group B streptococci carrying R protein.母亲针对R蛋白的IgG抗体水平低与携带R蛋白的B族链球菌所致新生儿败血症之间的相关性。
Int Arch Allergy Appl Immunol. 1983;71(2):168-72. doi: 10.1159/000233382.
10
Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes.B族链球菌Ibc蛋白抗原:两种决定簇在常见血清型野生型菌株中的分布
J Clin Microbiol. 1984 Apr;19(4):506-10. doi: 10.1128/jcm.19.4.506-510.1984.